Pharma Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Pharma Tech Outlook
By Slava Akmaev, SVP, Chief Analytics Officer, Co-founder & Head of Berg Analytics, BERG Health
A handful of companies have been using AI methodologies in target discovery by analyzing vast amounts of data.
By Blythe Lawton, Senior Director, First Associates Loan Servicing
Using Artificial Intelligence to record every call and interaction offers the necessary customer insight to improve key service areas.
By Douglas Barta, CIO, PAREXEL International
Technology plays a critical role in helping the biopharmaceutical industry navigate the complex drug development journey. There are a number of technologies available to help simplify the process, many of which can make drug development faster, more precise, trackable, and productive.
By Rishi Kakar, MD, Chief Scientific Officer, Segal Trials
The key to a CRO’s success lies in its ability to understand the issues faced by clinical research sites when conducting a study.
By Ajay Shah, Director, Research Informatics and Systems Division, City of Hope
Top ten highest grossing drugs in the US help between 25 to 40 percent people who take them. Precision Medicine (PM) approach promises better-informed, stratified and personalized patient care decisions and therapeutic discoveries.
By Jinesh Jain, Director of Clinical Technology, Somnoware Healthcare Systems Inc.
The rapid adoption of cloud computing in routine clinical practice has led to the incubation of several promising SaaS startups.
By Michael Marino, SVP and Chief Medical Information Officer, Providence St. Joseph Health
We are in the process of moving to a single EMR system called Epic, across our large, multi-state health system.
By Kevin Dawson, VP, Information Services, Los Angeles Biomedical Research Institute
IT executives are expected to be business leaders responsible for the information services function from end-to-end and not just the custodians of the IT infrastructure.
By Michael Swanick, Global Pharmaceutical and Life Sciences Industry Leader, PwC
Technological advances, empowered consumers, disruptive new entrants, and rising demand by an aging population are ushering in a new era in healthcare—what we at PwC call the “New Health Economy.”
By Gustavo Salem, Group President at IDEX Health & Science LLC
Here, we work closely to get the right costs, manufacturability and performance quality.
By Mario Harik, CIO, XPO Logistics, Inc.
The retailer can see rapid improvements in inventory management, supplier relations and consumer satisfaction - all of which decrease costs and increase confidence in the supply chain.
By Jason Sankey, CIO, Franklin County
The Sarbanes-Oxley Act of 2002 (SOX) changed the way the U.S. looked at managing risk and compliance in the investment banking technology space. It is hard to believe that we soon will see the 15th anniversary of SOX.
By Bozidar Jovicevic, VP, Global Head of Digital Medicines, Sanofi
Technology has aided the pharma and life sciences industry in employing genomics and artificial intelligence (AI) for speeding up drug R&D course.
By Michael Swanick, Global Pharmaceutical and Life Sciences Industry Leader, PwC
Technological advances, empowered consumers, disruptive new entrants, and rising demand by an aging population are ushering in a new era in healthcare
By Dr. Chris Stout, VP - Research & Data Analytics, ATI Physical Therapy
One of the primary, and arguably most important uses of data in healthcare is to accurately prescribe treatment.
